Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-28

Clinical Trial Update: Tetraspan 6 Percent (%) Combined With Sterofundin ISO Versus Albumin 5 Percent (%) Combined With Sodium Chloride (NaCL) [Phase 4]

View source ↗

Summary

The Phase 4 trial comparing Tetraspan 6% with Sterofundin ISO versus Albumin 5% with Sodium Chloride in patients with renal insufficiency was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin 5% (Human serum albumin)
  • Sodium chloride 0.9% (sodium chloride 0.9%)
  • Sterofundin ISO
  • Tetraspan 6%

Snippet

Sponsor: B. Braun Melsungen AG | Conditions: Renal Insufficiency | Phase 4 | Status: TERMINATED